This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: Exelon, Medtronic, Potash, Southwest Airlines

NEW YORK (TheStreet) -- RATINGS CHANGES

NOW (DNOW) was initiated at Barclays with an equal-weight rating. Offers leverage to the upcycle in capital spending in the industry, Barclays said. Twelve-month price target is $33.

Exelon (EXC) was upgraded at Jefferies to buy from hold. Valuation call, with 12-month price target of $42.50, Jefferies said.

Medtronic (MDT - Get Report) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $73. Covidien (COV) deal makes both financial and strategic sense, RBC Capital said.

Public Service Enterprise Group (PEG) was upgraded at Jefferies to buy from hold. Driven by improving commodity outlook for forward power prices, Jefferies said. Twelve-month price target is $44.

Potash (POT) was downgraded to hold at TheStreet Ratings.

Southwest Airlines (LUV - Get Report) was upgraded at Stifel Nicolaus to buy from hold. Twelve-month price target is $30. Recent industry pullback has created a buying opportunity, Stifel Nicolaus said.

JTH Holding (TAX) was upgraded to buy at TheStreet Ratings.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

Priceline Was a Winner for Investors Even Before OpenTable

United Pilots: We Flew to Chengdu on a 787 and Loved It

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
LUV $33.57 1.50%
MDT $73.87 -0.31%
AAPL $126.12 0.55%
FB $86.57 0.94%
GOOG $519.06 -0.28%

Markets

DOW 17,699.44 +79.93 0.45%
S&P 500 2,071.89 +8.78 0.43%
NASDAQ 5,000.7560 +13.8890 0.28%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs